Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate Cuschieri

Showing results (91-100 of 132) with videos related to

Pageof 14
Sort By:
Cancers|April 12, 2022
Development and Validation of a Raman Spectroscopic Classification Model for Cervical Intraepithelial Neoplasia (CIN)Damien Traynor, Shiyamala Duraipandian, Ramya Bhatia, et al.
Journal of Clinical Pathology|November 21, 2014
Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisationDavid Mesher, Kate Cuschieri, Sam Hibbitts, et al.
International Journal of Cancer|October 2, 2020
Effective methylation triage of HPV positive women with abnormal cytology in a middle-income countryArianis Tatiana Ramírez, Gloria Inés Sánchez, Belinda Nedjai, et al.
The Lancet. Infectious Diseases|October 3, 2017
Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional studyKimberley Kavanagh, Kevin G Pollock, Kate Cuschieri, et al.
International Journal of Cancer|September 25, 2021
Clinical performance of methylation as a biomarker for cervical carcinoma in situ and cancer diagnosis: A worldwide studyCristiana Banila, Attila T Lorincz, Dorota Scibior-Bentkowska, et al.
Virology|February 14, 2006
Methylation of the human papillomavirus-18 L1 gene: a biomarker of neoplastic progression?Tolga Turan, Mina Kalantari, Itzel E Calleja-Macias, et al.
Journal of Virological Methods|October 24, 2018
Development of an in-house ELISA to detect anti-HPV16-L1 antibodies in serum and dried blood spotsRamya Bhatia, June Stewart, Sharon Moncur, et al.
BMC Cancer|May 8, 2020
Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screeningDitte Møller Ejegod, Camilla Lagheden, Ramya Bhatia, et al.
Tumour Virus Research|May 13, 2023
Diversity of cervicovaginal human papillomavirus (HPV) genotypes and naturally occurring E6/E7 DNA polymorphisms of HPV-16 in GhanaGladys Kaba, Andrew Stevenson, Samuel Asamoah Sakyi, et al.
International Journal of Cancer|January 18, 2018
Eurogin roadmap 2017: Triage strategies for the management of HPV-positive women in cervical screening programsKate Cuschieri, Guglielmo Ronco, Attila Lorincz, et al.
Pageof 14

Showing results (91-100 of 132) with videos related to

Sort By:
Pageof 14
Cancers|April 12, 2022
Development and Validation of a Raman Spectroscopic Classification Model for Cervical Intraepithelial Neoplasia (CIN)Damien Traynor, Shiyamala Duraipandian, Ramya Bhatia, et al.
Journal of Clinical Pathology|November 21, 2014
Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisationDavid Mesher, Kate Cuschieri, Sam Hibbitts, et al.
International Journal of Cancer|October 2, 2020
Effective methylation triage of HPV positive women with abnormal cytology in a middle-income countryArianis Tatiana Ramírez, Gloria Inés Sánchez, Belinda Nedjai, et al.
The Lancet. Infectious Diseases|October 3, 2017
Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional studyKimberley Kavanagh, Kevin G Pollock, Kate Cuschieri, et al.
International Journal of Cancer|September 25, 2021
Clinical performance of methylation as a biomarker for cervical carcinoma in situ and cancer diagnosis: A worldwide studyCristiana Banila, Attila T Lorincz, Dorota Scibior-Bentkowska, et al.
Virology|February 14, 2006
Methylation of the human papillomavirus-18 L1 gene: a biomarker of neoplastic progression?Tolga Turan, Mina Kalantari, Itzel E Calleja-Macias, et al.
Journal of Virological Methods|October 24, 2018
Development of an in-house ELISA to detect anti-HPV16-L1 antibodies in serum and dried blood spotsRamya Bhatia, June Stewart, Sharon Moncur, et al.
BMC Cancer|May 8, 2020
Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screeningDitte Møller Ejegod, Camilla Lagheden, Ramya Bhatia, et al.
Tumour Virus Research|May 13, 2023
Diversity of cervicovaginal human papillomavirus (HPV) genotypes and naturally occurring E6/E7 DNA polymorphisms of HPV-16 in GhanaGladys Kaba, Andrew Stevenson, Samuel Asamoah Sakyi, et al.
International Journal of Cancer|January 18, 2018
Eurogin roadmap 2017: Triage strategies for the management of HPV-positive women in cervical screening programsKate Cuschieri, Guglielmo Ronco, Attila Lorincz, et al.
Pageof 14